Cannabinoids and Sickle Cell
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Cannabinoids and Sickle Cell
-
ナレーター：
-
著者：
このコンテンツについて
During this First Friday conversation, Marijuana Matters talks about Cannabinoids and Sickle Cell Disease (SCD). SCD affects approximately 8% of African Americans, and is characterized by chronic pain and episodic acute pain caused by Vaso occlusive crises, often requiring high doses of opioids for prolonged periods. Evidence is growing that cannabis may help people manage pain from SCD. However, only nine states include sickle cell as an approved health condition for medical marijuana. This conversation was moderated by Marijuana Matters Executive Director Courtney Davis, SCD advocate Demitrious Wyant aka AR the Prophet, and Cannabis Nurse Rebecca Abraham, CEO, and Founder of Acute on Chronic, LLC.
Stay tuned by following Marijuana Matters on these platforms:
- @marijuanamattersdc (IG)
- Marijuana Matters (LinkedIn)
- @socialequitymatters (Facebook)